Monica Else
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.
Journal: Leukemia
Published: October 13, 2025
Telomere length and DNA methylation epitype both provide independent prognostic information in CLL patients; data from the UK CLL4, ARCTIC and ADMIRE clinical trials.
Journal: British journal of haematology
Published: June 11, 2024
Hairy cell leukemia variant and WHO classification correspondence Re: 5th edition WHO classification haematolymphoid tumors: lymphoid neoplasms.
Journal: Leukemia
Published: December 04, 2023
Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Journal: Blood cancer journal
Published: September 18, 2022
Development of a distributed international patient data registry for hairy cell leukemia.
Journal: Leukemia & lymphoma
Published: September 07, 2022
The association between deaths from infection and mutations of the BRAF, FBXW7, NRAS and XPO1 genes: a report from the LRF CLL4 trial.
Journal: Leukemia
Published: October 26, 2020
Early clinical trials in chronic lymphocytic leukaemia in the UK.
Journal: British journal of haematology
Published: July 14, 2020
Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial.
Journal: Leukemia
Published: July 25, 2019
The morphology of CLL revisited: the clinical significance of prolymphocytes and correlations with prognostic/molecular markers in the LRF CLL4 trial.
Journal: British journal of haematology
Published: February 01, 2016
Last Updated: 09/26/2026